Avid Bioservices Inc (CDMO)

[senrex]

Thanks to Jazz's summary, I was able to deliver PPHM's Bavituximab story to my broker (he has procured all of my shares over the past ten years and had just done the same thing for another client to the tune of 15000 shares). My broker then forwarded Jazz's info to an oncologist client for his scrutiny. Several days later he was speaking with the oncologist who told him that he "had heard of Peregrine" from colleagues who had attended a medical conference (unfortunately, he didn't name it). The oncologist said that the report he had received viewed Peregrine in a very favorable light. He added, however, that Peregrine's work was not unique. I suggested to my broker that he was probably looking at the "mab" part of "Bavituximab" when he made the observation. The fact that he would not offer his opinion about Jazz's summary specifically confirms my view that there are oncologists and then there are oncologists. Still, I thought his comment about Peregrine being viewed favorably by colleagues was interesting and just thought I'd pass it along.

Sean